John Clarke

VISICU, Inc. provides information technology and clinical solutions for healthcare industry. It offers eICU program, a remote monitoring system for intensive care units. The company was founded by Brian Rosenfeld and Michael J. Breslow in 1998 and is headquartered in Baltimore, MD.

Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.

DNX Corp. provides pre-clinical drug development services to the pharmaceutical and biotechnology industry. The private company is based in Princeton, NJ and has subsidiaries in Switzerland and France. The company was founded by John K. Clarke, Steven H. Holtzman.

Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA.

DSV Partners IV LP invests in companies located in North America. The fund targets companies operating in the fields of electronics, communications, biotechnology and healthcare. It provides financing for seed and early stage capital requirements.

The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME.

Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.

Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT.

Abide Therapeutics, Inc. develops medicines that target serine hydrolases. Its approach is to selectively block serine hydrolases, potentially expanding this class of commercially validated enzymes as targets in a range of indications. The firm has a technology platform that exploits a chemoproteomics approach to selectively target serine hydrolases and rapidly identify target lead pairs. The company was founded by Alan B. Ezekowitz, Dale Boger, John Kennedy Clarke, Benjamin F. Cravatt, Todd Jones, Keith F. Lenden, and Paul R. Schimmel in 2011 and is headquartered in San Diego, CA.

Ivenix, Inc. operates as a medical device company. It develops and supplies infusion systems and intravenous-infusion pumps that eliminate air in the fluid bag line. The company was founded by John L. Bakos and Jeffrey Carlisle in 2007 and is headquartered in Amesbury, MA.

National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC.

Philadelphia Industrial Development Corp. engages in the provision of leverage financing and real estate resources. It offers business loans, project development finance, tax advantaged financing, grants administration and additional resources, and real estate which include navy yard, industrial land and city owned property. The company was founded in 1958 and is headquartered in Philadelphia, PA.

Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.

Prealize Health, Inc. engages in the development of machine learning solutions for improving healthcare focusing on predicting impending medical conditions. It specializes in data sciences and healthcare. The company was founded by Arnold Milstein and Nigam Shah in 2013 and is headquartered in Palo Alto, CA.

Cureatr, Inc. engages in the provision of comprehensive medication management solutions. Its solutions include meds 360, medication management, care transitions, secure messaging, and meds 360 for population. The company was founded by Joseph Mayer and Alex Khomenko in October 2011 and is headquartered in New York, NY.